| Abstract: | Pt?Au nanoclusters decorated on the surface of reduced graphene oxide (rGO/Pt?Au) was facilely prepared by one‐pot electrochemical reduction. The morphology and composition of rGO/Pt?Au composites had been characterized by scanning electron microscopy (SEM) coupled with energy‐dispersive X‐ray spectrometry (EDX), fourier transform‐infrared spectroscopy (FT‐IR) and electrochemical methods. Ofloxacin is a member of synthetic quinolones which has been widely used for the treatment of common diseases in humans and animals. The performance of the rGO/Pt?Au nanocomposite toward the oxidation of ofloxacin was compared with the other similar nanostructures like rGO/Pt and rGO/Au. In the optimized conditions, two linear calibration curves were obtained, from 0.08 to 10 μM and 10 to 100 μM ofloxacin. A detection limit of 0.05 μM ofloxacin was observed at pH 5.7 for the GCE/rGO/Pt?Au. The proposed sensor was successfully applied to determine ofloxacin in tablets and human urine samples and the results were satisfactory. |
